City

Berlin (1)

Condition

Malignant Ascites Due to Epithelial Carcinoma (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Neovii Biotech (1)

Collaborator

Intervention

catumaxomab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

malignant ascites due to epithelial carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Malignant Ascites Due to Epithelial Carcinoma Trial in Berlin (catumaxomab)

Completed

Malignant Ascites Due to Epithelial Carcinoma

catumaxomab

Berlin, Germany

Charité Campus Virchow Clinic

Oct 2, 2012